Ning Leng, a statistician trained in computational genetics who led R, Shiny, Git and cloud adoption at Roche/Genentech, discusses how the R Consortium drives collaborative regulatory submission pilots with the FDA. She covers interactive reproducible submissions using Shiny and WebAssembly, containerized workflows, and early pilots exploring generative AI for clinical trials. She also explains how benchmarking and community resources support responsible AI use.
18:25
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
question_answer ANECDOTE
From Statistician To R Innovation Lead
Ning Leng moved from being a statistician into leading an innovation team at Roche Genentech to drive R, cloud, Git, and Shiny adoption.
She started an R user community teaching packages, Shiny, and Git which led to a formal adoption strategy and cross-industry work.
insights INSIGHT
Practical Examples Were The Missing Piece
The real barrier to R submissions was lack of practical examples, not FDA policy, since FDA has stated they don't require a specific language.
Companies feared FDA rejection, so public mock submissions were created to show traceability and reproducibility with R.
insights INSIGHT
R Consortium As Cross Industry Collaboration Hub
The R Consortium is a nonprofit platform promoting R across industries and hosts working groups that enabled pharma collaboration with the FDA.
Active pharma groups include the Submissions Working Group and a Validation Hub producing white papers and quality-metrics tools.
Get the Snipd Podcast app to discover more snips from this episode
If you work in statistics, data science, statistical programming, or clinical development, this episode will give you a practical look at how the industry is moving toward more modern and collaborative approaches.
You’ll learn:
How the R Consortium is helping pharmaceutical companies work together and collaborate with the FDA.
What the R Consortium’s regulatory submission pilots can teach you about using R in real-world submissions.
How open-source collaboration can influence regulatory guidance and industry practices.
How tools like R, Shiny, containers, and WebAssembly could make regulatory submissions more interactive and reproducible.
How the community is beginning to explore generative AI for clinical trials and statistical programming.
Why benchmark datasets, challenging test cases, and quality control will be critical for using AI responsibly.
How you can explore the R Consortium’s public resources and get involved in its work.
Whether you’re already using R or simply want to understand where statistical programming and regulatory submissions are heading, this conversation with Ning Leng will give you valuable insights into the future of our field.
Episode highlights with timestamps
01:30 — Meet Ning Leng and her journey into R Ning introduces her background in statistics and computational genomics and explains how she became involved in R adoption, cloud migration, Git, and Shiny at Roche Genentech.
03:57 — Why R wasn't being used for regulatory submissions Ning explains the misconception that the FDA did not accept R and identifies the real challenge: the industry lacked practical examples showing how to submit R-based materials.
05:46 — What is the R Consortium? We discuss the R Consortium's role as a nonprofit organization that promotes good practices and the use of R across industries.
06:16 — How the R Consortium collaborates with the FDA Ning explains the submission working group, validation hub, and how the Consortium provides a platform for collaboration between pharmaceutical companies and the FDA.
08:13 — R Consortium FDA submission pilots Ning walks through the different pilots, from submitting TLGs to incorporating Shiny, ADaM code, containers, WebAssembly, and alternative data formats.
10:29 — How companies are using the pilot submissions We explore how pharmaceutical companies use the public R Consortium pilots as practical templates when preparing their own R-based regulatory submissions.
11:24 — How collaboration influenced FDA guidance Ning explains how lessons from the pilots helped clarify FDA guidance around file formats, including .r and .zip files.
12:17 — Moving beyond PDF-based electronic submissions We discuss the opportunity to use interactive graphics, HTML, Shiny, and other modern technologies to make electronic regulatory submissions more useful and traceable.
14:14 — Generative AI enters the picture Ning explains how the R Consortium is beginning to explore generative AI for clinical trial reporting, trial design, and statistical programming.
15:12 — Building AI skills and benchmark test cases We discuss open-source AI skills, benchmark datasets, and the importance of testing AI against difficult and unusual corner cases.
16:28 — How you can get involved with the R Consortium Ning shares practical ways to explore the community, including its public working-group materials, meeting minutes, recordings, and Slack channel.
Links and Resources:
🔗 R Consortium: Learn more about the R Consortium and its work to promote the use of R and good practices across industries: https://r-consortium.org/
🔗 R Consortium R Submissions Working Group: Explore the working group's projects, meeting materials, submission pilots, and opportunities to get involved: https://rconsortium.github.io/submissions-wg/
🔗 R Consortium 2026 Plans and 2025 Success: Read about the latest work from the R Submissions Working Group, including the development of Pilots 6 and 7: https://r-consortium.org/posts/submissions-wg-2026/
🔗 My New Book: How to Be an Effective Statistician - Volume 1– It’s packed with insights to help statisticians, data scientists, and quantitative professionals excel as leaders, collaborators, and change-makers in healthcare and medicine.
Join the Conversation: Did you find this episode helpful? Share it with your colleagues and let me know your thoughts! Connect with me on LinkedIn and be part of the discussion.
Subscribe & Stay Updated: Never miss an episode! Subscribe to The Effective Statistician on your favorite podcast platform and continue growing your influence as a statistician.